相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phenotypic Characterization of Idiosyncratic Drug-Induced Liver Injury: The Influence of Age and Sex
M. Isabel Lucena et al.
HEPATOLOGY (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
Sensitivity of Liver Injury in Heterozygous Sod2 Knockout Mice Treated with Troglitazone or Acetaminophen
Kazunori Fujimoto et al.
TOXICOLOGIC PATHOLOGY (2009)
Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-induced Liver Injury in the United States
Naga Chalasani et al.
GASTROENTEROLOGY (2008)
Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury
M. Isabel Lucena et al.
HEPATOLOGY (2008)
What is idiosyncratic hepatotoxicity? What is it not?
John R. Senior
HEPATOLOGY (2008)
Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals
Craig Lammert et al.
HEPATOLOGY (2008)
Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome
Ketevan Pachkoria et al.
JOURNAL OF HEPATOLOGY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
A. Kindmark et al.
PHARMACOGENOMICS JOURNAL (2008)
Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity
Daniel F. Carr et al.
PHARMACOGENETICS AND GENOMICS (2007)
Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status
T. A. Ajith et al.
FOOD AND CHEMICAL TOXICOLOGY (2007)
Genetic pollymorphism and function of glutathione S-transferases in tumor drug resistance
Hui-Wen Lo et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
The potent protective effect of wild ginseng (Panax ginseng CA Meyer) against benzo[α]pyrene-induced toxicity through metabolic regulation of CYP1A1 and GSTs
Sang Il Gum et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury
Yi-Shin Huang et al.
JOURNAL OF HEPATOLOGY (2007)
MRP2 haplotypes confer differential susceptibility to toxic liver injury
Ji Ha Choi et al.
PHARMACOGENETICS AND GENOMICS (2007)
Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI)
K. Pachkoria et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury
Mohammed Bourdi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Mitochondrial abnonnalities - A link to idiosyncratic drug hepatotoxicity?
Urs A. Boelsterli et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Genetic susceptibility to diclofenac-induced hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 genotypes
Ann K. Daly et al.
GASTROENTEROLOGY (2007)
Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury
Carmen Lang et al.
PHARMACOGENETICS AND GENOMICS (2007)
The influence of various genotypes on the metabolic activity of NAT2 in a Chinese population
B Chen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity
B Ricaurte et al.
ANNALS OF PHARMACOTHERAPY (2006)
Genetic factors in the predisposition to drug-induced hypersensitivity reactions
M Pirmohamed
AAPS JOURNAL (2006)
Efficiency and power in genetic association studies
PIW de Bakker et al.
NATURE GENETICS (2005)
Genetic Epidemiology 7 - Genetic epidemiology and public health: hope, hype, and future prospects
GD Smith et al.
LANCET (2005)
Genetic Epidemiology 5 - What makes a good genetic association study?
AT Hattersley et al.
LANCET (2005)
Idiosyncratic drug hepatotoxicity
N Kaplowitz
NATURE REVIEWS DRUG DISCOVERY (2005)
Role of metabolism in drug-induced idiosyncratic hepatotoxicity
JL Walgren et al.
CRITICAL REVIEWS IN TOXICOLOGY (2005)
Incidence of drug-induced liver injury in medical inpatients
Y Meier et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Drug-induced hepatotoxicity 2005
WC Maddrey
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Induction of phase I, II and III drug metabolism/transport by xenobiotics
CJ Xu et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
Pharmacogenetic determinants of human liver microsomal alfeintanil metabolism and the role of cytochrome P450 3A5
TM Klees et al.
ANESTHESIOLOGY (2005)
Effect of genetic polymorphisms in cytochrome P450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs - Clinical relevance
J Kirchheiner et al.
CLINICAL PHARMACOKINETICS (2005)
Cytochrome P450 polymorphisms in geriatric patients - Impact on adverse drug reactions - A pilot study
T Egger et al.
DRUGS & AGING (2005)
Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type
T Mizutani et al.
DRUG METABOLISM REVIEWS (2005)
Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship
P Dorado et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Clinical consequences of cytochrome P4502C9 polymorphisms
J Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Clinical perspectives on xenobiotic-induced hepatotoxicity
B Gunawan et al.
DRUG METABOLISM REVIEWS (2004)
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity
GP Aithal et al.
HEPATOLOGY (2004)
Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types - A synopsis
HH Maurer et al.
THERAPEUTIC DRUG MONITORING (2004)
Regulation of CYP3A4 by the bile acid receptor FXR:: evidence for functional binding sites in the CYP3A4 gene
C Gnerre et al.
PHARMACOGENETICS (2004)
Pharmacogenetics and drug development: The path to safer and more effective drugs
AD Roses
NATURE REVIEWS GENETICS (2004)
Acute and clinically relevant drug-induced liver injury:: a population based case-control study
FJ de Abajo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Enterohepatic bile salt transporters in normal physiology and liver disease
GA Kullak-Ublick et al.
GASTROENTEROLOGY (2004)
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
RJ Andrade et al.
HEPATOLOGY (2004)
Senna-induced hepatitis in a poor metabolizer
U Seybold et al.
ANNALS OF INTERNAL MEDICINE (2004)
Leflunomide-induced acute hepatitis
C Sevilla-Mantilla et al.
DIGESTIVE AND LIVER DISEASE (2004)
Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations
AC Allabi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity
UA Boelsterli
TOXICOLOGY AND APPLIED PHARMACOLOGY (2003)
The metabolism of diclofenac - Enzymology and toxicology perspectives
W Tang
CURRENT DRUG METABOLISM (2003)
Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers
J Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus
I Watanabe et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease
Y Masubachi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Cytochrome p450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis
YS Huang et al.
HEPATOLOGY (2003)
The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria
A Sutton et al.
PHARMACOGENETICS (2003)
Policy developments in regulatory approval
R Temple
STATISTICS IN MEDICINE (2002)
Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment
SK Sharma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver
P Zhao et al.
HEPATOLOGY (2002)
Incidence of drug-induced hepatic injuries: A French population-based study
C Sgro et al.
HEPATOLOGY (2002)
Epidemiology and individual susceptibility to adverse drug reactions affecting the liver
D Larrey
SEMINARS IN LIVER DISEASE (2002)
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis
YS Huang et al.
HEPATOLOGY (2002)
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal et al.
LANCET (2002)
Protection against acetaminophen-induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase
M Bourdi et al.
HEPATOLOGY (2002)
Molecular genetics of CYP2D6:: Clinical relevance with focus on psychotropic drugs
L Bertilsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro
Ü Yasar et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Potential role of pharmacogenomics in reducing adverse drug reactions - A systematic review
KA Phillips et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Candidate gene case-control association studies: advantages and potential pitfalls
AK Daly et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Genetic polymorphism of cytochrome P4502C9 in a Caucasian and a black African population
MG Scordo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Haplotype tagging for the identification of common disease genes
GCL Johnson et al.
NATURE GENETICS (2001)
Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation
B Roy et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes
F Lakehal et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis
O Rosmorduc et al.
GASTROENTEROLOGY (2001)
Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite
CM Dieckhaus et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
CG Dietrich et al.
CARCINOGENESIS (2001)
An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen
KM Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
JL Staudinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of a reactive metabolite of terbinafine: Insights into terbinafine-induced hepatotoxicity
SL Iverson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Is diclofenac a valuable CYP2C9 probe in humans?
S Morin et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission
K Kassahun et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Mitochondria in steatohepatitis
D Pessayre et al.
SEMINARS IN LIVER DISEASE (2001)
Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi
CJ Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Idiosyncratic drug reactions: the reactive metabolite syndromes
SR Knowles et al.
LANCET (2000)
MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping
AJ Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis
GP Aithal et al.
PHARMACOGENETICS (2000)
Searching for genetic determinants in the new millennium
NJ Risch
NATURE (2000)
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity
T Simon et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy:: evidence for a defect in protein trafficking
PH Dixon et al.
HUMAN MOLECULAR GENETICS (2000)
Trovafloxacin-induced acute hepatitis
MI Lucena et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
